Attallah, A. A., S. O. Abdallah, M. M. Omran, K. Farid, and Y. M. Shaker,
"Assessment of Hepatic Fibrosis Stages in Hepatitis C Virus Infected Patients Using Biomarkers in the Blood",
Journal of American Science, vol. 7, issue 12, pp. 799-805, 2011.
AbstractBackground: An intensive research effort in the field of non-invasive evaluation of liver fibrosis has recently permitted the description of several blood markers of fibrosis, mainly in chronic hepatitis C (CHC) patients. Our aim was to evaluate the diagnostic performance of a panel of simple blood markers of liver fibrosis in CHC patients. Materials and Methods: One hundred and thirty two patients with CHC evaluated for deciding on antiviral therapy were included. We used receiver operating characteristic (ROC) curves and a stepwise combination algorithm was developed to assess and compare the diagnostic accuracy of blood markers. Results: The areas under the ROC curves of AST/ALT ratio, albumin, platelet count, APRI and fibronectin for discriminating advanced liver fibrosis (F3-F4) were 0.58, 0.73, 0.76 , 0.73 and 0.74; respectively. The AUC of combined markers score based on AST-ALT ratio, albumin, fibronectin and platelets count was 0.86 for advanced liver fibrosis patients. The combined markers correctly classified 35 positive patients from 43 patients with 81% sensitivity and classified 64 patients as negative from a total of 89 patients with 72% specificity. Discussions.we have developed multivariate discriminate analysis (MDA), a function may contribute to differentiating advanced fibrosis in patients with CHC. The MDA function is based on easily and routinely analyzed four blood markers as noninvasive, reproducible, quantitative, precise, accurate and low cost method that can be applied to patients who either have contraindications or refuse liver biopsy for the management of their HCV infection.
Mohamed, M., I. M. Moussa2, K. F. Mohamed, A. Samir, E. A. Nasr, M. H.Ashgan, S. AlRejaie, and M. E. Hatem,
"BACTEC MGIT 960 TM system for screening of Mycobacterium Tuberculosis Complex Among Cattle",
African Journal of Biotechnology, vol. 10, pp. 13919-13923, 2011.
Amer, H. M.,
"Baculovirus Expression Vector System: an Efficient Tool for the Production of Heterologous Recombinant Proteins",
African Journal of Biotechnology, vol. 10, issue 32, pp. 5927-5933, 2011.
AbstractToday, the recombinant proteins become a major foundation of different industrial sectors. Products ofthese industries enhance the fields of medicine, pharmacology, agriculture, nutrition, petrochemicals,paper, textiles and many others. Since the mid 1980s, recombinant DNA technology has enabled thedevelopment of a wide diversity of vectors for expression of the desired recombinant protein innumerous prokaryotic and eukaryotic organisms. Baculovirus expression vector system is consideredone of the most successful and widely acceptable means for the production of recombinant proteins inextremely large quantities.
Abu-Taleb, A. M., K. E. - Deeb, and F. O. Al-Otibi,
"Bioactivity of some Plant Extracts Against Drechslera Biseptata and Fusarium Solani",
Journal of Food, vol. 9, pp. 769-774, 2011.
AbstractPhytochemical screening of Alhagi maurorum, Calotropis procera and Datura innoxia extracts revealed the presence of carbohydrates and/or glycosides, tannins, flavonoids, steroids and/or triterpenes. Moreover, anthraquinones were detected in A. maurorum and C. procera whereas alkaloids were detected in D. innoxia only. When ethyl alcohol extract prepared from D. innoxia was further fractionated by petroleum ether and chloroform, three fractions were detected. Four triterpenes subfractions (D1-D4) were isolated from petroleum ether fraction and identified as ?- amyrin, daturadiol, daturadiol-3-acetate and daturaolone. Chloroform fraction contained alkaloids which were fractionated into 3 subfractions (D5- D7) and identified as atropine, hyoscine and hyoscyamine. Two coumarin subfactions were isolated from the remaining aqueous layer and identified as scopoletin and scopolin. All the selected plant extracts were effective in inhibiting growth, sporulation, conidial germination as well as cellulase and pectinase enzymes of Drechslera biseptata and Fusarium solani, except the remaining aquaeous layer fraction of ethanolic extract prepared from D. innoxia which exhibited stimulatory effect on spore production and nonsignificant effect on conidial germination as well as cellulase and pectinase enzymes of D. biseptata. Mostly F. solani was more susceptible to plant extracts than D. biseptata. It was evident that the antifungal activity of the plant extracts depended upon type of plant, solvent, extract concentration as well as fungal type and its phase of growth.
Rawi, S. M., I. M. Mourad, and D. A.Sayed,
"Biochemical Changes in Experimental Diabetes Before and Aftertreatment with Mangifera Indica and Psidium Guava Extracts",
Int J Pharm Biomed Sci., vol. 2, pp. 29-41, 2011.
AbstractMale adult albino rats were used to study the hypoglycemic effect of Mangiferaindica and Psidium guajava aqueous extracts either used individually or incombination of as well as the effect of glibenclamide as reference sulfonylureasdrug at the dose level of 0.5 mg/kg body weight in streptozotocin-diabetic rats.Preliminary test using different doses of each plant indicated that the most effectivedoses were 250 mg/kg body weight for each plant. Our studies was extended toinclude the effect of the tested doses on different biochemical parameters includingserum insulin concentration, hepatic glycogen content, total proteins, total lipidsand transaminases activities in serum and liver. The obtained data of the abovementioned investigations revealed great alleviation of the impaired glucose tolerance, serum insulin and hepatic glycogen content, also serum and hepatic totalprotein contents were increased as a result of treatment. In STZ-diabetic rats, theactivities of (ALT, AST and ALP) either detected in sera or hepatic tissues wereincreased, then the activities were improved as a result of treatments.